Drug-induced hyperglycaemia and diabetes is a global issue. It may be a serious problem,
as it increases the risk of microvascular and macrovascular complications, infections …

Over the last years, the metabolic role of PRL has emerged. PRL excess is known to
promote weight gain, obesity, metabolic syndrome, and impairment in gluco-insulinemic and …

New information about the effects of prolactin (PRL) on metabolic processes warrants re-
evaluation of the overall metabolic actions of PRL. PRL affects metabolic homeostasis by …

Hyperprolactinemia might be related to weight gain, metabolic syndrome (MS), and insulin
resistance (IR). Treatment with dopamine agonist (DA) has been shown to reduce body …

Background: Weight gain is a common adverse effect associated with the use of most
antipsychotic drugs. Leptin has been reported to be associated with antipsychotic-induced …

Objective It has recently been shown that increased body weight is associated with
prolactinomas and that weight loss occurs with normalization of prolactin levels. On the other …

BACKGROUND: Many adverse effects of atypical antipsychotic treatment are associated
with antagonism of monoamine receptors; however, data indicate that important metabolic …

Psychiatrists have become particularly concerned about health issues in patients with
schizophrenia because of emerging data that link some of the newer atypical antipsychotics …

Background: The onset of diabetes and impaired glucose metabolism among schizophrenic
patients has been the topic of numerous recently published articles, with research …

Weight gain is a frequent and important side effect of psychopharmacotherapy. Recent
studies suggest that the fat-cell-derived hormone leptin and the tumor necrosis factor-α (TNF …